97 related articles for article (PubMed ID: 29895364)
1. Influence of boric acid on energy metabolism and stress tolerance of Candida albicans.
Schmidt M; Tran-Nguyen D; Chizek P
J Trace Elem Med Biol; 2018 Sep; 49():140-145. PubMed ID: 29895364
[TBL] [Abstract][Full Text] [Related]
2. Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans.
Pointer BR; Boyer MP; Schmidt M
Yeast; 2015 Apr; 32(4):389-98. PubMed ID: 25612315
[TBL] [Abstract][Full Text] [Related]
3. Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans.
Larsen B; Petrovic M; De Seta F
Mycopathologia; 2018 Apr; 183(2):349-357. PubMed ID: 28993976
[TBL] [Abstract][Full Text] [Related]
4. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
[TBL] [Abstract][Full Text] [Related]
5. Boric acid-dependent decrease in regulatory histone H3 acetylation is not mutagenic in yeast.
Pointer BR; Schmidt M
FEMS Microbiol Lett; 2016 Jul; 363(13):. PubMed ID: 27190149
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of boric acid, triclosan and zinc oxide against different clinically relevant Candida species.
Gavilanes-Martínez MA; Coral-Garzón A; Cáceres DH; García AM
Mycoses; 2021 Sep; 64(9):1045-1052. PubMed ID: 33969547
[TBL] [Abstract][Full Text] [Related]
7. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
8. Boric Acid Inhibition of Trichophyton rubrum Growth and Conidia Formation.
Schmidt M
Biol Trace Elem Res; 2017 Dec; 180(2):349-354. PubMed ID: 28391495
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of Candida albicans and other medically important yeasts by vaginal contraceptive products.
Shubair M; Larsen B
Gynecol Obstet Invest; 1990; 29(1):67-70. PubMed ID: 2161785
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
Romano L; Battaglia F; Masucci L; Sanguinetti M; Posteraro B; Plotti G; Zanetti S; Fadda G
J Antimicrob Chemother; 2005 Jan; 55(1):110-4. PubMed ID: 15574476
[TBL] [Abstract][Full Text] [Related]
11. Candida albicans strain differentiation in complete denture wearers.
Abu-Elteen KH
New Microbiol; 2000 Jul; 23(3):329-37. PubMed ID: 10939048
[TBL] [Abstract][Full Text] [Related]
12. 2-amino-nonyl-6-methoxyl-tetralin muriate activity against Candida albicans augments endogenous reactive oxygen species production --a microarray analysis study.
Liang RM; Yong XL; Jiang YP; Tan YH; Dai BD; Wang SH; Hu TT; Chen X; Li N; Dong ZH; Huang XC; Chen J; Cao YB; Jiang YY
FEBS J; 2011 Apr; 278(7):1075-85. PubMed ID: 21251230
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
Messier C; Epifano F; Genovese S; Grenier D
Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
[TBL] [Abstract][Full Text] [Related]
16. A new simple method for biotyping Candida albicans.
Williamson MI; Samaranayake LP; MacFarlane TW
Microbios; 1987; 51(208-209):159-67. PubMed ID: 3316937
[TBL] [Abstract][Full Text] [Related]
17. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
[TBL] [Abstract][Full Text] [Related]
18. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
19. Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans.
Wu XZ; Cheng AX; Sun LM; Sun SJ; Lou HX
Biochim Biophys Acta; 2009 Aug; 1790(8):770-7. PubMed ID: 19446008
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
